References
Feb 1, 1991·Gut·S A RileyM E Herd
Dec 24, 1987·The New England Journal of Medicine·K W SchroederD M Ilstrup
Jun 17, 1998·Cellular Immunology·R M GorczynskiZ Cohen
Jul 9, 2002·Pathology International·Seiji ArihiroHiroshi Nagura
Jan 3, 2003·The New England Journal of Medicine·David H MillerUNKNOWN International Natalizumab Multiple Sclerosis Trial Group
Nov 17, 2004·Journal of Clinical Pharmacology·Youssef HijaziRichat Abbas
Oct 21, 2005·Immunology·Roberto González-AmaroFrancisco Sánchez-Madrid
Nov 4, 2005·The New England Journal of Medicine·William J SandbornUNKNOWN Evaluation of Natalizumab as Continuous Therapy (ENACT-2) Trial Group
May 9, 2007·Gastroenterology·Stephan R TarganUNKNOWN International Efficacy of Natalizumab in Crohn's Disease Response and Remission (ENCORE) Trial Group
May 15, 2007·Lancet·Daniel C Baumgart, Simon R Carding
Jul 17, 2007·Drug Discovery Today·Richard J Davenport, James R Munday
Apr 9, 2008·Inflammatory Bowel Diseases·Bertus EksteenDavid H Adams
Jul 29, 2009·Inflammatory Bowel Diseases·Gary R Lichtenstein, Paul Rutgeerts
Feb 15, 2011·Gut·Séverine VermeireWojciech Niezychowski
May 3, 2011·Gastroenterology·Eduardo J VillablancaJ Rodrigo Mora
Jul 5, 2011·Gastroenterology·Jean Frédéric ColombelWilliam J Sandborn
Jul 23, 2011·Lancet Neurology·Ludwig KapposJohn King
Dec 8, 2011·Inflammatory Bowel Diseases·Asit ParikhBrian G Feagan
Jan 10, 2012·Lancet Neurology·David H MillerXavier Montalban
May 18, 2012·The New England Journal of Medicine·Gary BloomgrenCarmen Bozic
Nov 14, 2012·The American Journal of Gastroenterology·Kavinderjit S NandaAlan C Moss
Apr 30, 2013·Journal of Crohn's & Colitis·Toshihiko SugiuraHiroyuki Eda
Aug 24, 2013·The New England Journal of Medicine·Brian G FeaganUNKNOWN GEMINI 1 Study Group
Aug 24, 2013·The New England Journal of Medicine·William J SandbornUNKNOWN GEMINI 2 Study Group
Oct 19, 2013·Current Neurology and Neuroscience Reports·Joshua J Chalkley, Joseph R Berger
May 13, 2014·Lancet·Séverine VermeirePaul Rutgeerts
Citations
Jan 30, 2016·Expert Opinion on Investigational Drugs·Leon P McLean, Raymond K Cross
Oct 28, 2015·Gastroenterology·Barrett G Levesque, Subrata Ghosh
Mar 12, 2016·Expert Opinion on Investigational Drugs·Ole Haagen NielsenMehmet Coskun
Oct 5, 2016·Clinical Journal of Gastroenterology·Makoto NaganumaTakanori Kanai
Mar 16, 2017·Inflammatory Bowel Diseases·Sebastian Zundler, Markus F Neurath
Apr 7, 2018·Human Vaccines & Immunotherapeutics·Ignacio Catalan-Serra, Øystein Brenna
Oct 21, 2017·Therapeutic Advances in Gastroenterology·Marcel Vetter, Markus F Neurath
Sep 9, 2017·The Cochrane Database of Systematic Reviews·Vipul JairathBrian G Feagan
Apr 27, 2018·Alimentary Pharmacology & Therapeutics·C MaV Jairath
Jul 10, 2018·Expert Opinion on Investigational Drugs·Mariangela AlloccaSilvio Danese
May 17, 2018·Journal of Crohn's & Colitis·Christopher A LambEugene C Butcher
Nov 18, 2018·Expert Opinion on Therapeutic Patents·Hao LiJi-Fu Wei
May 11, 2018·Immunopharmacology and Immunotoxicology·Christian L HvasJørgen Agnholt
Apr 25, 2019·Current Gastroenterology Reports·Tushar Shukla, Bruce E Sands
Mar 28, 2017·EMBO Molecular Medicine·Juanjuan LiYing Yu
May 28, 2019·Gut·Sebastian ZundlerMarkus F Neurath
Jun 20, 2019·Medicinal Research Reviews·Iris DotanJacqueline McBride
Jul 13, 2017·Clinical Pharmacology and Therapeutics·Pieter HindryckxSilvio Danese
Aug 3, 2017·Annals of the Rheumatic Diseases·Kenneth F Baker, John D Isaacs
Jan 23, 2020·Clinical Drug Investigation·Hiroyuki FukaseHidetoshi Furuie
Oct 29, 2019·British Journal of Clinical Pharmacology·Hiroyuki FukaseHidetoshi Furuie
Oct 1, 2019·Current Opinion in Gastroenterology·Sebastian ZundlerMarkus F Neurath
Apr 14, 2020·European Journal of Gastroenterology & Hepatology·Laura A LucaciuAndrada Seicean
Jul 12, 2017·Frontiers in Pharmacology·Diego CurròAlessandro Armuzzi
Sep 30, 2017·Journal of Crohn's & Colitis·Pieter HindryckxBrian G Feagan
Apr 20, 2018·Alimentary Pharmacology & Therapeutics·J R WhiteG W Moran
May 10, 2018·World Journal of Gastroenterology : WJG·Sung Chul Park, Yoon Tae Jeen
Nov 18, 2018·Inflammatory Bowel Diseases·Kenechukwu O Chudy-OnwugajeRaymond K Cross
Apr 12, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Xiao DingFaming Zhang
Mar 27, 2020·International Journal of Molecular Sciences·Andrea HärzschelTanja Nicole Hartmann
Jun 16, 2017·Expert Review of Clinical Immunology·Julian Panés, Ignacio Alfaro
Dec 21, 2018·Alimentary Pharmacology & Therapeutics·Christopher MaVipul Jairath
Jan 2, 2019·World Journal of Gastroenterology : WJG·Elisabetta AntonelliGabrio Bassotti
Aug 24, 2018·F1000Research·Jan Wehkamp, Eduard F Stange
Aug 24, 2018·Journal of Crohn's & Colitis·Julián Panés, Azucena Salas
Dec 28, 2018·Inflammatory Bowel Diseases·Fabio Salvatore MacalusoAmbrogio Orlando
Jul 19, 2019·Drugs·Christopher MaVipul Jairath
Jun 18, 2019·Therapeutic Advances in Gastroenterology·João SabinoMarc Ferrante
Apr 25, 2020·Intestinal research·Emiko MizoguchiToshiyuki Okada
Jul 15, 2020·Digestive Diseases and Sciences·Neil NadparaFrank Friedenberg
Aug 31, 2018·Inflammatory Bowel Diseases·Tamara Pérez-JeldresJesús Rivera-Nieves
Sep 12, 2020·Nature Reviews. Disease Primers·Taku KobayashiToshifumi Hibi
Jul 1, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Marisol VenyJulián Panés
Mar 26, 2021·Archives of Pharmacal Research·Ki-Uk KimChang Hwan Choi
Apr 7, 2019·Trends in Molecular Medicine·Sruthi Vijaya Retnakumar, Sylviane Muller
May 4, 2021·Frontiers in Pharmacology·Badr Al-BawardyDeborah D Proctor
May 22, 2021·Frontiers in Immunology·Maximilian WiendlSebastian Zundler
Aug 10, 2021·Expert Opinion on Investigational Drugs·Berta CaballolAzucena Salas
Aug 28, 2021·Expert Opinion on Investigational Drugs·Virginia SolitanoSilvio Danese
Sep 2, 2021·Clinical and Experimental Gastroenterology·John GubatanSidhartha Sinha